Quest Diagnostics (DGX) Capital Expenditures (2009 - 2026)

Quest Diagnostics has reported Capital Expenditures for 18 years, with the latest figure at $138.0 million in Q2 2026.

• Quarterly Capital Expenditures rose 27.78% year-over-year to $138.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $554.0 million (up 22.03% YoY) and the FY2025 annual result came in at $527.0 million, up 24.0% from the prior year.
• Capital Expenditures improved to $138.0 million in Q2 2026 per DGX's latest filing, from $114.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $158.0 million in Q4 2025 and troughed at $63.0 million in Q1 2022.
• A 5-year average of $112.0 million and a median of $111.0 million in 2025 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 101.59% in 2023, down 51.02% in 2023.
• Over 5 years, Capital Expenditures stood at $147.0 million in 2022, then plunged by 51.02% to $72.0 million in 2023, then jumped by 70.83% to $123.0 million in 2024, then gained by 28.46% to $158.0 million in 2025, then decreased by 12.66% to $138.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $138.0 million, $114.0 million, and $158.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.